{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,5]],"date-time":"2022-04-05T15:23:47Z","timestamp":1649172227751},"reference-count":9,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Enfermedades Infecciosas y Microbiolog\u00eda Cl\u00ednica"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1016\/j.eimc.2015.10.008","type":"journal-article","created":{"date-parts":[[2015,12,2]],"date-time":"2015-12-02T15:39:40Z","timestamp":1449070780000},"page":"536-537","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Meropenem y \u00e1cido valproico: interacci\u00f3n farmacol\u00f3gica cl\u00ednicamente relevante"],"prefix":"10.1016","volume":"34","author":[{"given":"Elena","family":"S\u00e1nchez-Y\u00e1\u00f1ez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clara","family":"Esta\u00fan-Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guillermo","family":"Ojeda Burgos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.eimc.2015.10.008_bib0005","series-title":"Interacciones farmacol\u00f3gicas","author":"Baxter Stockley","year":"2007"},{"key":"10.1016\/j.eimc.2015.10.008_bib0010","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.nrl.2011.03.008","article-title":"An\u00e1lisis de la interacci\u00f3n \u00e1cido valproico-meropenem en pacientes hospitalizados","volume":"27","author":"V\u00e9lez D\u00edaz-Pallar\u00e9s","year":"2012","journal-title":"Neurologia"},{"key":"10.1016\/j.eimc.2015.10.008_bib0015","unstructured":"Micromedex\u00ae Solution. Interacciones de f\u00e1rmacos [consultado Sep 2015]. Disponible en: http:\/\/www.micromedexsolutions.com"},{"key":"10.1016\/j.eimc.2015.10.008_bib0020","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1345\/aph.1K079","article-title":"Interaction between valproate and meropenem: A retrospective study","volume":"41","author":"Spriet","year":"2007","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.eimc.2015.10.008_bib0025","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1080\/03602530701690341","article-title":"Interaction between valproic acid and carbapenem antibiotics","volume":"39","author":"Mori","year":"2007","journal-title":"Drug Metab Rev"},{"key":"10.1016\/j.eimc.2015.10.008_bib0030","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1177\/0091270009334377","article-title":"Valproic acid plasma concentration decreases in a dose-independent manner following administration of meropenem: A retrospective study","volume":"49","author":"Haroutiuian","year":"2009","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.eimc.2015.10.008_bib0035","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1097\/FTD.0b013e318260f7b3","article-title":"Reduced valproic acid serum concentrations due to drug interactions with carbapenem antibiotics: Overview of 6 cases","volume":"34","author":"Park","year":"2012","journal-title":"Ther Drug Monit"},{"key":"10.1016\/j.eimc.2015.10.008_bib0040","unstructured":"Ficha t\u00e9cnica Meronem iv 1 g. Polvo para soluci\u00f3n inyectable y para perfusi\u00f3n. [consultado Sep 2015]. Disponible en: http:\/\/www.aemps.gob.es\/cima\/pdfs\/es\/ft\/60640\/FT_60640.pdf"},{"key":"10.1016\/j.eimc.2015.10.008_bib0045","first-page":"1","article-title":"In vivo inhibition of acylpeptide hydrolase by carbapenem antibiotics causes the decrease of plasma concentration of valproic acid in dogs","volume":"15","author":"Suzuki","year":"2015","journal-title":"Xenobiotica"}],"container-title":["Enfermedades Infecciosas y Microbiolog\u00eda Cl\u00ednica"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0213005X15003808?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0213005X15003808?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,17]],"date-time":"2018-09-17T03:20:14Z","timestamp":1537154414000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0213005X15003808"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,10]]},"references-count":9,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2016,10]]}},"alternative-id":["S0213005X15003808"],"URL":"https:\/\/doi.org\/10.1016\/j.eimc.2015.10.008","relation":{},"ISSN":["0213-005X"],"issn-type":[{"value":"0213-005X","type":"print"}],"subject":[],"published":{"date-parts":[[2016,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Meropenem y \u00e1cido valproico: interacci\u00f3n farmacol\u00f3gica cl\u00ednicamente relevante","name":"articletitle","label":"Article Title"},{"value":"Enfermedades Infecciosas y Microbiolog\u00eda Cl\u00ednica","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.eimc.2015.10.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2015 Elsevier Espa\u00f1a, S.L.U. and Sociedad Espa\u00f1ola de Enfermedades Infecciosas y Microbiolog\u00eda Cl\u00ednica. All rights reserved.","name":"copyright","label":"Copyright"}]}}